Search research articles
Contact Us
Filters
Showing results (1-10 of 149) with videos related to
Page
of 15
Sort By:
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
January 3, 2007
Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond
B Dahlöf
International Journal of Clinical Practice. Supplement
|
May 27, 1999
Definition of high blood pressure, epidemiology and goals of hypertension treatment
B Dahlöf
American Journal of Hypertension
|
March 13, 2001
Left ventricular hypertrophy and angiotensin II antagonists
B Dahlöf
American Heart Journal
|
October 1, 1987
The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: influence on small arteries
B Dahlöf
Cor Et Vasa
|
January 1, 1990
Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review
B Dahlöf
International Journal of Clinical Practice. Supplement
|
February 29, 2000
ACE inhibitors: the evidence in hypertension
B Dahlöf
Journal of Human Hypertension
|
August 8, 2008
Management of cardiovascular risk with RAS inhibitor/CCB combination therapy
B Dahlöf
Drugs
|
January 1, 1988
Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review
B Dahlöf
Journal of Human Hypertension
|
August 3, 2005
Further evidence for low-dose combinations in patients with left ventricular hypertrophy
B Dahlöf
Blood Pressure. Supplement
|
January 1, 1992
Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy
B Dahlöf
Page
of 15
Search research articles
Search
Showing results (1-10 of 149) with videos related to
Sort By:
Page
of 15
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS
|
January 3, 2007
Valsartan and the renin-angiotensin-aldosterone system: blood pressure control and beyond
B Dahlöf
International Journal of Clinical Practice. Supplement
|
May 27, 1999
Definition of high blood pressure, epidemiology and goals of hypertension treatment
B Dahlöf
American Journal of Hypertension
|
March 13, 2001
Left ventricular hypertrophy and angiotensin II antagonists
B Dahlöf
American Heart Journal
|
October 1, 1987
The role of antihypertensive pharmacologic treatment in countering adverse pathophysiological profiles: influence on small arteries
B Dahlöf
Cor Et Vasa
|
January 1, 1990
Cardiovascular effects of isradipine (Lomir) with special emphasis on haemodynamics and antihypertensive efficacy. A review
B Dahlöf
International Journal of Clinical Practice. Supplement
|
February 29, 2000
ACE inhibitors: the evidence in hypertension
B Dahlöf
Journal of Human Hypertension
|
August 8, 2008
Management of cardiovascular risk with RAS inhibitor/CCB combination therapy
B Dahlöf
Drugs
|
January 1, 1988
Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review
B Dahlöf
Journal of Human Hypertension
|
August 3, 2005
Further evidence for low-dose combinations in patients with left ventricular hypertrophy
B Dahlöf
Blood Pressure. Supplement
|
January 1, 1992
Structural cardiovascular changes in essential hypertension. Studies on the effect of antihypertensive therapy
B Dahlöf
Page
of 15